CONMED CORPORATION Goodwill, Acquired During Period
CONMED CORPORATION (CNMD) reported Goodwill, Acquired During Period of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2024-02-28
- CONMED CORPORATION goodwill, acquired during period for the quarter ending 2022-12-31 was $170.00K.
- CONMED CORPORATION goodwill, acquired during period for the quarter ending 2022-09-30 was $58.65M.
- CONMED CORPORATION goodwill, acquired during period for the quarter ending 2019-12-31 was $1.69M.
- CONMED CORPORATION goodwill, acquired during period for the quarter ending 2019-09-30 was $0.00.
- CONMED CORPORATION goodwill, acquired during period for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CONMED CORPORATION goodwill, acquired during period for fiscal 2022 was $199.16M.
- CONMED CORPORATION goodwill, acquired during period for fiscal 2021 was $0.00.
- CONMED CORPORATION goodwill, acquired during period for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Goodwill, Acquired During Period | Goodwill, Acquired During Period as first filed | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month | Goodwill, Acquired During Period 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 | ||||||
| 2022-12-31 | $170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $58.82M derived: sum of 2 quarters · filed 2024-02-28 | $199.16M 10-K · filed 2024-02-28 | ||||
| 2022-09-30 | $58.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $198.99M 10-Q · filed 2022-10-27 | |||||
| 2022-06-30 | $140.34M 10-Q · filed 2022-07-28 | ||||||
| 2021-12-31 | $0.00 10-K · filed 2023-02-21 | ||||||
| 2020-12-31 | $0.00 10-K · filed 2021-02-22 | ||||||
| 2019-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $1.69M derived: sum of 2 quarters · filed 2021-02-22 | $2.69M derived: sum of 3 quarters · filed 2021-02-22 | $217.48M 10-K · filed 2021-02-22 | |||
| 2019-12-04 | $700.00K 10-K · filed 2021-02-22 | $1.70M 10-K · filed 2020-02-24 | |||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $1.00M derived: sum of 2 quarters · filed 2019-10-31 | $215.79M 10-Q · filed 2019-10-31 | ||||
| 2019-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $215.79M 10-Q · filed 2019-08-01 | |||||
| 2019-03-31 | $214.79M 10-Q · filed 2019-04-26 | ||||||
| 2019-02-11 | $215.80M 10-K · filed 2021-02-22 | $214.80M 10-Q · filed 2019-04-26 | |||||
| 2018-12-31 | $0.00 10-K · filed 2020-02-24 | ||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $0.00 derived: sum of 2 quarters · filed 2019-02-25 | $2.21M 10-K · filed 2019-02-25 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $2.21M 10-Q · filed 2017-11-02 | |||||
| 2017-06-30 | $2.21M 10-Q · filed 2017-07-27 | ||||||
| 2016-12-31 | $329.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $329.00K derived: sum of 2 quarters · filed 2018-02-26 | $329.00K derived: sum of 3 quarters · filed 2018-02-26 | $136.69M 10-K · filed 2018-02-26 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $0.00 derived: sum of 2 quarters · filed 2016-10-28 | $136.36M 10-Q · filed 2016-10-28 | $136.36M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $136.36M 10-Q · filed 2016-07-28 | $136.36M derived: sum of 3 quarters · filed 2017-02-27 | $136.36M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2016-03-31 | $136.36M 10-Q · filed 2016-05-02 | $136.36M derived: sum of 2 quarters · filed 2017-02-27 | $136.36M derived: sum of 3 quarters · filed 2017-02-27 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $0.00 derived: sum of 2 quarters · filed 2017-02-27 | $5.37M 10-K · filed 2017-02-27 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-23 | $5.37M 10-Q · filed 2015-10-23 | |||||
| 2015-06-30 | $5.37M 10-Q · filed 2015-07-27 | ||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $7.77M 10-K · filed 2016-02-23 | |||||
| 2014-09-30 | $7.77M 10-Q · filed 2014-10-24 | ||||||
| 2013-12-31 | $0.00 10-K · filed 2015-02-23 | ||||||
| 2012-12-31 | -$8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $13.70M 10-K · filed 2014-02-24 | -$22.02M 10-K · filed 2013-02-25 | ||||
| 2012-09-30 | $22.00M 10-Q · filed 2012-10-29 | ||||||
| 2011-12-31 | $0.00 10-K · filed 2013-02-25 | ||||||
| 2010-12-31 | -$4.38M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |